Cystathionase activity was absent from human fetal liver and brain as early as 6 weeks of gestation. Hepatic methionine-activating enzyme (26 ± 3 nmoles/mg protein/hr) and hepatic cystathionine synthase (21 ± 4 nmoles/mg protein/hr) were present (cf. 86 ±16 and 98 ± 19 nmoles/mg protein/hr, respectively, in mature human liver). All three activities were absent from the placenta. Human fetal liver contained higher concentrations of cystathionine (14 ± 2 /xmoles/100 g wet weight) than mature human liver (0) and human fetal brain (4.0 ± 0.6 ,umoles/100 g wet weight). Methionineactivating enzyme of human fetal brain, but not liver, showed a tendency to increase with development (coefficient of correlation was 0.62; 0.01 < P < 0.05).
Introduction
known about the early development of these pathways. Although there is considerable information on control
In normal adult humans, about 90% of ingested meof the metabolism of sulfur-containing amino acids thionine is converted to cyst(e)ine [21] , a nonessential and transsulfuration in mature humans, little is amino acid, via the transsulfuration pathway ( Fig. 1 ).
Development of mammalian sulfur metabolism 539 A key intermediate of this pathway is cystathionine, which is normally present in high concentrations in human brain [30] , but which is virtually absent from brain of patients with homocystinuria owing to deficiency of cystathionine synthase [3] . Little cystathionine is present in liver of mature humans [3, 30] . A single report presented fragmentary evidence that the concentration of cystathionine in human fetal brain might be lower than that in brain of mature humans [18] . We have therefore examined the development of the transsulfuration pathway in 58 human fetuses obtained at therapeutic abortion during approximately the 2nd-6th month of gestation and in liver from 5 full term and 3 prematurely born infants. We found that cystathionase activity develops sometime after birth in man and that the placenta does not subserve the transsulfuration function. We suggest that cyst-(e)ine may be an essential amino acid in the developing human.
Materials and Methods
The activities of methionine-activating enzyme (adenosine triphosphate: L-methionine S-adenosyltransferase, EC. 2.5.1.6), cystathionine synthase (L-serine hydrolyase (adding homocysteine), EC. 4.2.1.21) [33] and cystathionase (L-homoserine hydro-lyase (deaminating), EC. 4.2.1.15) were measured in both human and animal tissues by previously described methods [8, 9] . Concentrations of amino acids in the various tissues were measured by minor modifications of the method of Spademan, Moore and Stein [24] . For "in vivo" experiments, each fetus immediately after removal from the uterus was injected with approximately 100 //.Ci of either 35 S-L-methionine (specific activity 515 mCi/mmole) or 35 S-L-cysteine (specific activity 31.3 mCi/mmole) [34] contained in 0.5 ml of a 0.9% solution of NaCl at pH 7.0. In some experiments, unlabeled cysteine (2.0 /xmoles L-cysteine in 0.2 ml 0.9% NaCl, pH 7.0) as well as 35 S-L-methionine were injected. All injections were made into the umbilical vein through a short Teflon catheter which was then rinsed with 0.2 ml 0.9% NaCl; the whole cord was clamped on the fetal side of the point of entry of the catheter to prevent blood loss during the experiment. After 10 min, the cord was severed close to the fetus, and as much blood as possible was collected into a tube which contained heparin as anticoagulant. The fetal organs were quickly removed and dropped into liquid nitrogen. The plasma and organs were prepared for amino acid analysis as described previously [26] . Radioactivity was measured by passing the column effluent, before it was mixed with ninhydrin reagent, through a 1-ml flow cell (packed with anthracene) in a scintillation counter [27] . Protein was purified from the precipitates and specific activity was determined [27] .
In in vitro experiments, approximately 50 mg fresh, minced liver were incubated in 0.5 ml Krebs-Ringer phosphate buffer, pH 7.4, which contained 1 mg D-glucose/ml and either 10 ^Ci S-L-cysteine. After incubation for 1 hr at 37°, 0.5 ml 10% trichloroacetic acid was added and the tissues were then homogenized.
Included in this study are tissues and physiologic fluids from the following: 58 human fetuses (2.5-20.5 cm crown-rump length) obtained at therapeutic abortion; 4 prematurely born infants (weight: 830, 1000, 1060, and 1260 g) who died during the first day of life; 1 infant (1500 g at birth), born after a 35-week gestation, who died after 96 hr of life of pulmonary hemorrhage; 1 full term infant who died after 7 hr of an intraabdominal hemorrhage secondary to a catheter accident; 1 full term infant who died after 72 hr with congenital heart disease; and 1 full term infant [35] who, after 96 hr of life, died in deep coma with severe metabolic acidosis and cystathioninuria. All abortions were by hysterotomy. Preoperative medications included: Pethidine, 50-75 mg; Phenergan, 25 mg; and atropine, 0.5-0.8 mg intramuscularly. Anaesthesia was induced with 250-440 mg Pentothal intravenously and was maintained with N 2 O 2 . Scoline was used as muscle relaxant. All mothers were in apparently good health; abortions were performed for social or psychologic reasons.
Results

Enzymatic Assays and Cystathionine Concentration in Fetal Liver
The most striking observation in crude extracts of liver from 24 human fetuses, in contrast with results [8] previously obtained with crude extracts of liver from control subjects (minimum age, 2.5 years), was that cystathionase activity was absent (Table I) . Modification of the assay by varying the concentration of cystathionine (0^t ^moles/tube) or by varying the pH (6.5-9.0) failed to elicit any measurable activity of cystathionase. The possibility that a soluble or loosely bound inhibitor of cystathionase was present in crude extracts of human fetal liver was tested by incubating these extracts with crude extracts of rat liver; no change in cystathionase activity in the rat liver was found, which would suggest that such an inhibitor was not present. Three mothers received 200 mg pyridoxine-HCl/24 hr for 2 weeks prior to abortion; activity of cystathionase in liver from these three fetuses was also absent.
The activities of cystathionine synthase and methionine-activating enzyme in liver extracts were approximately one-fourth to one-third of the activities found in similar preparations from mature humans (Table  I ). There was no correlation between either enzymatic activity and fetal crown-rump length.
Cystathionine, the substrate of cystathionase, was present in fetal liver in relatively high concentrations ( Table I ). The concentration of cystathionine in fetal liver was lower than that observed in adult human brain [3, 30] , but it was higher than in immature brain of the same fetuses (Table II) . There was no apparent correlation between the concentration of cystathionine in fetal liver and the crown-rump length of the fetus over the period of gestation examined; the results are therefore expressed as the mean of the group plus or minus the standard error of the mean.
Enzymatic Assays and Cystathionine Concentration in Fetal Brain
Similar results for all three enzymes on the pathway of transsulfuration were obtained in brains from the Development of mammalian sulfur metabolism 541 same fetuses (Table II) . Valid comparison with mature human brain is not possible, of course, because biopsy controls cannot be obtained. However, in Table II there are given the activities of these enzymes as well as the concentrations of cystathionine in selected areas of the brain, obtained at autopsy, from a 6-month-old infant with so-called "hereditary tyrosinemia" [7] . It should also be noted that values for the "control" brain may represent a minimum estimate of the activities of methionine-activating enzyme and cystathionine synthase, since it was shown that these activities are considerably reduced in crude extracts of liver from patients with so-called "hereditary tyrosinemia." The only difference among these three enzymatic activities in brain and in liver is that methionine-activating enzyme in crude brain extracts (Table II) showed a tendency to increase with fetal development (coefficient of correlation was 0.62; 0.01 < P < 0.05). The concentrations of cystathionine in brains of human fetuses were lower than those in the corresponding livers (cf . Tables  I and II) . Again, there was no apparent correlation between concentration of cystathionine in fetal brain and crown-rump length of the fetus over the period of gestation examined; the results are therefore expressed as the mean of the group plus or minus the standard error of the mean.
Enzymatic Assays and Cystathionine Concentration in Liver from Neonates
Results obtained from assay of the three enzymatic activities in extracts of liver from premature infants who died during the 1st day of life are similar (Table  I ). An infant, who weighed 1500 g, who was probably of 35-week gestation and "small-for-date," and who died 4 days after birth, showed considerable cystathionase activity. Three full term infants were also available for study: one infant who died 7 hr after birth had barely detectable cystathionase activity; one who died 3 days after birth had low-normal cystathionase activity; and one, who died 4 days after birth with cystathioninuria which had been noted on the 2nd-3rd day, had normal cystathionase activity. In general, the concentration of cystathionine in livers from neonates was inversely related to the specific activity of cystathionase that had developed.
From these meager results, it is apparent that development of cystathionase in human liver is a postnatal phenomenon. In fact, cystathionase activity reached the level found in mature human liver more quickly than did the activities of methionine-activating enzyme and cystathionine synthase; in the newly-born infant, the levels of activity of all three enzymes are similar to those found in the fetus. The postnatal pattern of development of these enzymatic activities requires further detailed study.
Enzymatic Assays and Concentration of Cystathionine in Placenta
Crude extracts of placenta obtained from the fetuses had no measurable cystathionase, cystathionine synthase, methionine-activating enzyme, or cystathionine. Previously examined crude extracts from placentas of term infants likewise had very low activities of transsulfuration enzymes [28] .
Activity of Cystathionase in Fetal Liver of Other Species
Cystathionase activity in liver of fetal rats at 18 and 20 days of gestation was of the same order of magnitude as that of the mother. Liver from fetal mouse and fetal gerbil showed similar high activities of cystathionase at the late stage of gestation investigated. Liver of fetal guinea pig near term (>55 days of a 65-day gestation) had almost mature levels of cystathionase, but no activity was found in liver at an early stage of gestation (<35 days). Liver of fetal rabbit had no measurable cystathionase activity at approximately 15 days gestation, and only a trace of activity was detected at approximately 25 days of the 31-day gestation. Liver of a newly born rabbit (<24 hr after birth) did have measurable activity, although it was well below mature levels. Liver of fetal rhesus monkey had no activity at a late stage of gestation (152 and 159 days), but liver of fetal baboon had cystathionase activity both at term and at a late stage of gestation (153 days). It therefore appears that the rhesus monkey and perhaps the rabbit may be closest to man with regard to the development of cystathionase activity in liver.
Studies of :i~' S-L-Methionine and &3 S-L-Cysteine "in Vivo"
35 S-L-methionine was injected into the umbilical vein of six human fetuses (6.0-to 16.4-cm crown-rump length) and its incorporation into the free amino acids and proteins of various tissues was measured after 10 min. During this period, the heart continued to beat and spontaneous movement was seen. Considerable 35 S-methionine was incorporated into free methionine in liver, brain, and plasma; however, there was no correlation between the amount of incorporated 35 Smethionine and the length of the fetus. Significant incorporation of 35 S from methionine into cystathionine was found only in the liver and brain of the smallest fetus (Table III) . When S-methionine (but, curiously, not 35 S-cysteine) was injected, an unknown peak, which has recently been identified as the mixed disulfide of cysteine and reduced glutathione, was found in liver and brain extracts. Why this occurred with one but not the other substrate is not clear, but it may be because the total activity incorporated into the free amino acid pool was greater in the case of 33 
Smethionine.
Under these conditions, there was no incorporation of 3B S from methionine into free cyst(e)ine, homocyst-(e)ine, or taurine; however, incorporation of 35 S-L-methionine into protein of fetal liver, brain and kidney was considerable (Table IV) . Two fetuses were large enough so that a quantity of protein sufficient for analysis could be obtained from the pancreas; incorporation of 83 S into proteins of the pancreas was greater than into proteins of any of the other three organs. 35 S-L-methionine was also injected into the umbilical vein of six human fetuses after an injection of unlabeled L-cysteine. Because of differences between fetuses, no conclusions could be drawn about the effect of unlabeled cysteine upon the incorporation of 3B S-Lmethionine into the proteins of these human fetal tissues and plasma. Again, more 35 S was incorporated into proteins of the pancreas than of any other organ in the same fetus.
3B
S-L-cysteine was similarly injected (Table V) into six human fetuses (6.9-to 15.5-cm crown-rump length). Radioactivity from L-cysteine was incorporated into free cysteine in liver and, to a lesser extent, in brain. Generally, less radioactivity was incorporated into free cystine in liver and brain than into cysteine; in plasma, however, more 35 S was incorporated into free cystine than into free cysteine. In all fetuses but one, radioactive cysteine was incorporated into cystathionine (Table III) S-L-cysteine into proteins was measured in the same six fetuses (Table VI) . Cysteine was actively incorporated into the protein of liver, brain, kidney, pancreas, and plasma, but, again, there was too much variation between fetuses to draw further conclusions. S-L-cysteine were incubated with minced liver from four fetuses (6.8-to 14.0-cm crown-rump length). There was active incorporation of 35 S into liver proteins from both labeled precursors (Table VII) . The addition of unlabeled cysteine to the Development of mammalian sulfur metabolism 543 incubation medium had little effect on incorporation of 35 S-L-methionine into the protein. This suggests that, under the conditions of these experiments, the cysteine pool in these fetuses was not rate-limiting for incorporation of methionine into protein.
Studies of s°S -Methionine and 3°S -Cysteine in Vitro
Discussion
Enzymatic Findings
The most striking finding in this study is the absence of cystathionase activity in human fetal liver and brain in the presence of considerable activity of methionine-activating enzyme and cystathionine synthase. Inasmuch as fetal liver contains large amounts of hematopoietic tissue, it is conceivable that the lower activities of the latter two enzymes might be, at least in part, a function of this fact; however, this cannot account for the complete absence of cystathionase. The possibility that the apparent absence of activity was due to different kinetic properties of an "immature" enzyme was reasonably ruled out by varying greatly the conditions of substrate concentration, cofactor concentration, and pH. The remote possibility that human fetal liver contains a soluble or looselybound inhibitor has been ruled out by incubating extracts of fetal liver with active extracts of rat liver. However, the question remains whether cystathionase is absent or is present but in an inactive state. Experiments with rabbit antibody to human liver cystathionase suggest that apocystathionase is absent from human fetal liver [19] .
Although the total number of specimens is few, it seems that appearance of cystathionase activity in human liver is a postnatal phenomenon; liver from a single full term infant who died 7 hr after birth had barely detectable activity and a large concentration of cystathionine, whereas two other full term infants who died at the ages of 4 and 5 days had one-half to twothirds normal activity and very little cystathionine. The four premature infants whom we were able to examine all died within a few hours after birth and had no cystathionase activity. A single infant, who was 35 weeks gestational age but who weighed only 1500 g and was therefore "small-for-date," died on the 5th day and the activity of cystathionase was about half that found in mature liver. The time of appearance of full enzymatic activity for both term and premature infants remains to be elucidated, but, by analogy to other enzymes which appear after birth, one would anticipate that there is considerable variation and that the process is likely to be slower in premature infants. The stimulus for the derepression or activation of the synthesis of this enzyme is unknown. A number of enzymes which appear postnatally are important in gluconeogenesis [17] . Inasmuch as cleavage of cystathionine by cystathionase yields <*-oxobutyrate and cysteine (which potentially yields pyruvate), it may be that this is an example of the more general phenomenon of synthesis of an enzyme only when it is needed functionally. Inasmuch as the cofactor and developmental pattern of cystathionase parallels that of tyrosine transaminase, an attempt was made to see whether cystathionase in the human fetus is responsive to coenzyme induction, the way that tyrosine transaminase is in postnatal rats [11] . Despite the fact that cystathionase in humans may increase after large doses of vitamin B 6 [8] , 300 mg pyridoxine/24 hr given to three mothers for 2 weeks prior to abortion failed to result in measurable activity of cystathionase in the fetus.
Of the three enzymes measured in fetal liver and fetal brain, only the methionine-activating enzyme of brain showed any change with development during the period of gestation studied. The increase that was found was similar to that found for the same enzyme in brain of developing monkey by Volpe and Laster [31] . This phenomenon is of interest in light of the potential regulatory role of methylation in the metabolism of biogenic amines.
Radioactive Studies
Further attempts were made to elucidate the metabolic interrelations by use of 30 S-methionine and 35 Scysteine. Interpretation of the "in vivo" experiments is limited: these compounds are relatively insoluble; the small blood volume and diverse physical dimensions of the various fetuses resulted in large, uncontrollable problems of radioisotope dilution; and the circulatory status of the fetuses was uncertain even though in all cases the heart continued to beat during the 10-min period. However, under the conditions of these experiments, methionine and cysteine were absorbed and distributed throughout the fetus and were incorporated into proteins of various organs in all cases. The in vitro experiments measuring incorporation into protein showed that protein synthesis, per se, was active and that, under these conditions, the endogenous pool of cysteine in fetal livers was not rate-limiting for synthesis of liver proteins. Inasmuch as the group of mothers was well nourished, the question of the effect of maternal nutrition in this regard awaits further study.
Of biochemical interest is the finding that significant 3D S-cystathionine was found in the liver of only one fetus when 33 S-L-methionine was injected, but it was found in the livers of five fetuses when 35 S-L-cysteine was injected, despite large concentrations of unlabelecl cystathionine in the livers of all fetuses (Table III) . The inability of 33 S-methionine to give rise to 35 S-cystathionine (except in one experiment) suggests that, although there is sufficient adenosine triphosphate present to synthesize some protein from the radioactive precursor, the amount is not sufficient to activate methionine to S-adenosylmethionine as well. The mechanism by which 33 S-cystathionine is formed from 35 S-cysteine is not clear. Cysteine, in place of serine, can serve as cosubstrate with homocysteine in the synthesis of cystathionine by serine sulfhydrase, which may be identical with cystathionine synthase [1] , but in this reaction the sulfur atom of cystathionine is derived from homocysteine and nonradioactive cystathionine would be formed from 30 S-cysteine. In the presence of homoserine, the sulfur atom from cysteine is incorporated into cystathionine by cystathionase acting in the reverse direction [9] , and, indeed, a crude extract of liver from a premature infant was able to synthesize cystathionine in vitro [9] , but cystathionase is lacking in fetal liver. Another possibility would be to invoke the presence of a separate "homoserine sulfhydrase" (cf. [1] ) which would form 35 S-cystathionine from 35 Scysteine and either homocysteine or homoserine by y cleavage.
The fact that 33 S-cysteine was incorporated largely into cysteine in liver and brain and into cystine in plasma (Table V) may be a reflection of the fact that there are relatively greater amounts of the disulfide extracellularly [4] and relatively greater amounts of the sulfhydryl form intracellularly.
Concentrations of Cystathionine in Tissues and Fluids
In mature humans, cystathionine is normally present in high concentration in brain and is usually present in low concentration in liver [3, 30] . In human fetuses, during the period of gestation studied, this situation is reversed: the concentration of cystathionine in liver is higher than that in brain for two reasons: (1) the concentration of cystathionine in fetal liver is higher than that in adult liver, and (2) the concentration of cystathionine in fetal brain is lower than that in adult brain. The latter finding in the 24 fetuses that we studied confirms the findings in the 2 fetuses studied by Okumura et al. [18] . Our results differ from those of Ryan and Carver [22] who reported concentrations of methionine in human fetal liver (22-24 weeks of gestation) which are far higher than any that we found. They made no mention of cystathionine; however, the analytical method that they employed might not separate adequately methionine and cystathionine. Since cystathionase is absent from both liver and brain, the fact that the concentrations of cystathionine in human fetal liver and brain differ from those in mature humans supports the contention that factors other than the ratio of cystathionine synthase to cystathionase control the concentration of cystathionine [28, 29] . Cystathionine was not found in fetal plasma or amniotic fluid despite the considerable concentrations found in liver and brain, a finding that is in accord with out previous studies which suggest that it is transported across cell membranes into the plasma only with difficulty [27] .
Possible Clinical Implications
The facts that cystathionase was absent from fetal brain and fetal liver and that all three activities of transsulfuration measured were absent from the placenta suggest that the fetus is entirely dependent upon the mother for its supply of cyst(e)ine, i.e., in the fetus of the human, cyst(e)ine may be an essential amino acid. Implications for nutritional supplementation of malnourished mothers are obvious.
Because preliminary results of our investigations of prematurely born and newly born human infants suggest that the initiation of cystathionase activity is a postnatal phenomenon, the question of the essentiality of cyst(e)ine in the neonatal period is germane. Experience with other enzymes which become active postnatally suggests that enzymatic activity matures during a rather wide range of time and that full activity is reached more slowly in the prematurely born infant. It seems likely, therefore, that cyst(e)ine may remain an essential amino acid until sometime after birth. In light of current interest in the effects on development of brain of nutritional deprivation during the early periods which are characterized by rapid cellular growth, the question of nutritional requirements for cystine should be systematically examined. It seems clear that the definition of "essential" must be made not only with reference to species, but also to particular organ and to particular stage of development.
For some years there has been a controversy in clinical pediatrics about the amount of protein that should be fed to low birth weight infants [5] . The evidence presented here suggests that the quantity of protein may not be as significant as its quality. In 1947, Gordon et al. [10] first suggested that premature infants who were fed a skimmed cow's milk formula gained weight more rapidly than those who were fed human milk. Although the formulas were isocaloric, they were not controlled for mineral content so that, in addition to higher protein concentration, the cow's milk also had a high mineral content, and, consequently, the infants who were fed cow's milk probably retained water. In 1967, Davidson and co-workers [6] , using only cow's milk formulas with controlled mineral content, concluded that a protein intake of 4 g/24 hr was "ideal." Their study established that 4 g cow's milk/24 hr is better than 2 g/24 hr, but it did not resolve the question of whether an infant needs a high protein formula if the protein is qualitatively similar to human milk. Cow's milk is higher in protein (about 3.6%) than human milk (about 1.1%) and the proteins differ qualitatively in that the lactalbumin/casein ratios in the two milks are approximately 18:82 and 60:40, respectively. Because casein is low in cystine, cow's milk is relatively high in methionine and low in cystine, whereas human milk is relatively high in cystine and low in methionine.
Additional studies suggest that infants of low birth weight grow more rapidly, or at least get heavier more rapidly, on high protein diets (2-4 times the protein in human milk), but at the expense of abnormal amino acid patterns in plasma [23] , increases in urea nitrogen, and pyrexia [5] . On the other hand, infants who were fed cow's milk, at a protein intake equivalent to that of human milk, showed increased incidence of edema and lower serum protein concentrations, and they did not gain weight as rapidly [5] . However, the critical feeding experiment has never been performed. We suggest that, because of the slow maturation of cystathionase, cyst(e)ine may be a first-limiting amino acid for protein synthesis and growth in infants of low birth weight during the critical early weeks of extrauterine life. Therefore, infants of low birth weight who are fed a formula with the same quality of protein as that in human milk should grow as well. The same reservation is relevant to the new vogue of using casein hydrolysates for prolonged intravenous alimentation of infants of low birth weight. High concentrations of plasma methionine in the presence of low concentrations of plasma cystine have been observed [25] .
This work has implications for another clinical problem of great potential interest: the relation between the metabolism of methionine and the production of arteriosclerosis as proposed by McCully [14] [15] [16] . In experimental and both hereditable types of homocystinuria, there were lesions in the arteries which resembled the early connective tissue changes of arteriosclerosis. The early arterial connective tissue lesions that occurred in rabbits following administration of homocysteine thiolactone were converted to lipoid plaques by the addition of excess cholesterol to the diet, but neither lesions nor plaques were produced when only excess cholesterol was present in the diet. In countries in which arteriosclerosis is most prevalent, the diets are characteristically high in protein fed at an early age, in addition to being rich in cholesterol and lipids. Since arteriosclerotic lesions are known to occur in infants (so-called "milk plaques") and since human milk is a low protein food, the current practice of using high protein feedings must be systematically studied, especially in light of the more limited ability of the immature human to catabolize methionine.
These enzymatic findings are also relevant to neonatal screening for metabolic diseases involving the metabolism of methionine. The absence of cystathionase provides a potential enzymatic explanation for the high frequency of cystathioninuria in premature infants [2] and possibly also for the high frequency of hypermethioninemia in infants who are fed diets rich in protein [12, 13] . This is probably analogous to the effect of the maturation of parahydroxyphenylpyruvic acid oxidase on the concentration of tyrosine in neonates. An example of the difficulty in diagnosis which this presents is the case of the infant with cystathioninuria who died in severe metabolic acidosis of unknown etiology on the 4th day of life with significant concentrations of cystathionine remaining in the liver; assay of liver extracts demonstrated considerable activity of cystathionase, albeit somewhat lower than normal.
Absence of cystathionase during the antenatal period has obvious implications in the genetic interpretation of data from enzymatic assays of cultured amniotic fluid cells. It seems unlikely that cystathioninuria caused by deficiency of cystathionase, if this is indeed a disease [20] , can be diagnosed prenatally. It points up the importance of understanding the developmental history of a particular enzyme before genetic diagnosis and intervention is attempted.
Conclusions
Activities of methionine-activating enzyme and cystathionine synthase were present in liver and brain of human fetuses as early as 6 weeks of gestation at 25-35% of the levels found in mature humans. Cystathionase activity did not appear until sometime after birth. None of these activities is present in placenta. Extracts of fetal liver were found to contain high concentrations o£ cystathionine, a compound that is barely measurable in adult human liver. Extracts of fetal brain contained less cystathionine than is present in adult human brain. Studies with 35 S-L-methionine and 33 S-L-cysteine indicated that protein synthesis could take place actively, and that liver could form radioactive cystathionine more readily from cysteine than from methionine, despite the absence of cystathionase.
Addendum
We have subsequently performed experiments using perfused human fetal liver (crown-rump length, 10-13 cm) by the technique of Kekomaki el al. [36] using 35 S-L-methionine [34] (2 mM, 200 ^Ci in a total volume of 70 ml) or 35 S-L-cysteine [34] (2 mM, 200 ^Ci in a total volume of 70 ml). The perfusions (two with each isotope) were continued for 3 hr, and the perfusate was sampled every 30 min. At the end of the experiment, part of the liver was homogenized with 3 volumes 10% trichloroacetic acid (TCA), and part was frozen for determination of cystathionase activity. All four livers showed zero activity of cystathionase when assayed by our usual method [8] , but, after concentration by lyophilization (approximately 7-fold), the presence of a trace of activity was indicated by immunochemical methods [19] . The perfusate and the TCA-soluble fractions were analyzed using an amino acid analyzer [39] coupled with a flow-cell scintillation counter [37] . In both experiments with 35 S-L-methionine, small amounts of 3r 'S-cystine were detected in the liver extract but none in the perfusate, and in both experiments with 35 S-Lcysteine, small amounts of 35 S-cystathionine were detected in the liver extract but none in the perfusate. These "small amounts" were easily measurable peaks of at least 4 times background, but they represented less than 0.1% of the radioactivity in the substrate in the same sample. These radioactive compounds occurred at positions on the chart where no radioactivity was detected in the substrates. Protein purified from the TCAinsoluble portion of the livers was highly radioactive (72, 50, 12, and 35 X 10 3 dpm/mg for the 2 methionine and the 2 cysteine perfusions, respectively) which indicates that the tissue was viable under these conditions. These experiments give further evidence that trace amounts of cystathionase activity and "homoserine sulfhydrase" and/or "reverse cystathionase" [38] activity are present in human fetal liver, as has been confirmed immunochemically [19] .
